Hopp til innhold
NHI.no
Annonse

Ménières sykdom: Symptomer

Innhold i artikkelen

Symptomene kan i starten være atypiske, og de kan arte seg som episoder med bare ett symptom, eksempelvis plutselige anfall med svimmelhet eller øresus. Etter en tid blir anfallene mer typiske med svimmelhet, kvalme og oppkast, øresus og svekket hørsel, og ofte trykkfølelse i det syke øret. Anfallene kommer plutselig uten foranledning og varer typisk fra 20 minutter til flere timer. Svimmelheten er ofte så sterk at man må legge seg ned under anfallet, men pasienten er hele tiden bevisst under anfallet.

Annonse

Etter anfallene er det vanlig med vedvarende kvalme, slitenhet og utmattelse. Nedsatt hørsel og eventuell døvhet er vanligvis kun tilstede på det ene øret, men 30-50 prosent vil etter hvert få symptomer også i det andre øret. Etter gjentatte anfall vil hørselen gradvis svekkes.

Omkring 95 prosent vil bli kvitt de store svimmelhetsanfallene over tid, men ubalanse kan vedvare, og hørselen blir oftest varig svekket.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Ménières sykdom . Referanselisten for dette dokumentet vises nedenfor

  1. Helsedirektoratet. Nasjonale retningslinjer for utredning, behandling og oppfølging av pasienter med Menières sykdom. Helsedirektoratet 2016. www.helsebiblioteket.no
  2. Ghossaini SN. Meniere's disease. BMJ Best Practice, last updated 18 Jun 2021. bestpractice.bmj.com
  3. Gürkov R, Pyykö I, Zou J, Kentala E. What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops. J Neurol 2016; Suppl 1: 71-81. pmid:27083887 PubMed
  4. Lopez-Escamez JA, Liu Y. Epidemiology and genetics of Meniere's disease. Curr Opin Neurol. 2024 Feb 1;37(1):88-94. PMID: 37865853. PubMed
  5. Klockars T, Kentala E. Inheritance of Meniere's disease in the Finnish population. Arch Otolaryngol Head Neck Surg. 2007; 133:73-7. PMID: 17224529 PubMed
  6. Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?. Otol Neurotol. 2005; 26:74-81 PMID: 15699723 PubMed
  7. Lopez-Escamez JA, Carey J, Chung W-H, et al. Diagnostic criteria for Menière's disease. J Vestib Res 2015; 25: 1-7. pmid:25882471 PubMed
  8. Basura GJ, Adams ME, Monfared A, et al. Clinical Practice Guideline: Ménière’s Disease. Otolaryngol Head Neck Surg 2020; 162: 414-34. pmid:32267820 PubMed
  9. Perez-Garrigues H, Lopez-Escamez JA, Perez P, et al. Time course of episodes of definitive vertigo in Meniere's disease. Arch Otolaryngol Head Neck Surg. 2008;134(11):1149-1154. PubMed
  10. Tamanini JB, Mezzalira R, Vallim MGB, et al. Dissociation between video head impulse test and caloric test: a marker of menière's disease? - A systematic review and meta-analysis. Braz J Otorhinolaryngol. 2023 Jul-Aug;89(4):101279. PMID: 37354884. PubMed
  11. Gottlieb M, Peksa GD, Carlson JN. Head impulse, nystagmus, and test of skew examination for diagnosing central causes of acute vestibular syndrome. Cochrane Database Syst Rev. 2023 Nov 2;11(11):CD015089. PMID: 37916744. PubMed
  12. Venhovens J, Meulstee J, Verhagen WI. Acute vestibular syndrome: a critical review and diagnostic algorithm concerning the clinical differentiation of peripheral versus central aetiologies in the emergency department. J Neurol. 2016 Nov;263(11):2151-2157. PMID: 26984607. PubMed
  13. Webster KE, Galbraith K, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, Ray J, Van Vugt VA, Burton MJ. Systemic pharmacological interventions for Ménière’s disease. Cochrane Database of Systematic Reviews 2023, Issue 2. Art. No.: CD015171. DOI: 10.1002/14651858.CD015171.pub2. Accessed 23 November 2023. The Cochrane Library
  14. Webster KE, George B, Galbraith K, et al. Positive pressure therapy for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 23;2(2):CD015248. PMID: 36815713. PubMed
  15. Lee A, Webster KE, George B, et al. Surgical interventions for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 24;2(2):CD015249. PMID: 36825750. PubMed
  16. Webster KE, Lee A, Galbraith K, et al. Intratympanic corticosteroids for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD015245. PMID: 36847608. PubMed
  17. Webster KE, Galbraith K, Lee A, et al. Intratympanic gentamicin for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD015246. PMID: 36847592. PubMed
  18. Moskowitz HS, Dinces EA. Meniere disease: Evaluation, diagnosis, and management. UpToDate, last updated Jan 15, 2021. UpToDate
  19. Shim T, Strum DP, Mudry A, Monfared A. Hold the Salt: History of Salt Restriction as a First-line Therapy for Menière's Disease. Otol Neurotol. 2020 Jul;41(6):855-859. PMID: 32221112. PubMed
  20. van Esch BF, van der Zaag-Loonen H, Bruintjes T, et al. Interventions for Menière's disease: an umbrella systematic review. BMJ Evid Based Med. 2022 Aug;27(4):235-245. PMID: 34750154. PubMed
  21. Crowson MG, Patki A, Tucci DL. A Systematic Review of Diuretics in the Medical Management of Meniere's Disease. Otolaryngol Head Neck Surg 2016; 154(5):824-34. PMID: 26932948 PubMed
  22. Adrion C, Fischer CS, Wagner J, et al. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 2016; 352: h6816. PMID: 26797774 PubMed
  23. Hanner P, Rask-Andersen H, Lange S, Jennische E. Antisecretory factor-inducing therapy improves the clinical outcome in patients with Meniere's disease. Acta Otolaryngol 2010;130(2):223-7. PMID: 19479454 PubMed
  24. Rizk H, Monaghan NP, Shah S, et al. Efficacy of a Serotonin-Norepinephrine Reuptake Inhibitor as a Treatment for Meniere Disease A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg 2024. pmid:39235772 PubMed
  25. van Sonsbeek S, Pullens B, van Benthem PP. Positive pressure therapy for Ménière's disease or syndrome. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD008419. DOI: 10.1002/14651858.CD008419.pub2 DOI
  26. Grønlund C, Devantier L, Callesen HE, et al. Vertiginous Episodes in Menière Disease following Transmyringeal Ventilation Tube Insertion: A Systematic Review on the Current State of Evidence. Int Arch Otorhinolaryngol. 2021 Jul;25(3):e463-e470. PMID: 34377186. PubMed
  27. Szott FA, Westhofen M, Hackenberg S. Is endolymphatic sac surgery an efficient treatment of Menière's disease patients? A systematic literature search and meta-analysis. Eur Arch Otorhinolaryngol. 2023 Mar;280(3):1119-1128. Erratum in: Eur Arch Otorhinolaryngol. 2022 Nov 9. PMID: 36208333. PubMed
  28. Patel M, Agarwal K, Arshad Q, et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Meniere`s disease: a randomised, double-blind, comparative effectiveness trial. Lancet. 2016. PMID: 27865535 PubMed
  29. Schlegel M, Vibert D, Ott SR, Häusler R, Caversaccio MD. Functional results and quality of life after retrosigmoid vestibular neurectomy in patients with Meniere's disease. Otol Neurotol 2012;33(8):1380-5. PMID: 22931868 PubMed
  30. Fife TA, Lewis MP, May JS, Oliver ER. Cochlear Implantation in Ménière's Disease. JAMA Otolaryngol Head Neck Surg 2014; 140: 535-9. PubMed
  31. Minor LB, Schessel DA, Carey JP. Ménière's disease. Curr Opin Neurol. 2004; 17):9-16. PMID: 15090872 PubMed
  32. Helsedirektoratet. Førerkortveileder: 7. Nevrologiske sykdommer: Morbus Menière. Nettsiden sist endret 02.12.29, og den ble besøkt 04.06.24.
Annonse
Annonse